Company Profile
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery.
Its portfolio also includes Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility, Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment, Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating, and Sentinel 4DCT, a laser-based optical surface scanning system
Catalyst, a 4D surface guided radiation therapy (SGRT) solution. Its portfolio also includes Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery, and visual coaching solutions used for prospective and retrospective radiotherapy.
Additionally, it offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, it offers support and training services; and service contracts. Incorporated in 2004, C-Rad AB (publ) is headquartered in Uppsala, Sweden.